About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Intravenous glucagon

Company: University Hospital Tuebingen
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details

Completed NCT NCT02012166

A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)

Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2005-12 Stand-alone

Type 2 diabetes
View official trial listing →
Status unknown NCT NCT02624830

Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)

Not yet reported Haukeland University Hospital 30 participants Est. completion 2020-02 1 site Stand-alone

Other conditions: Permanent Neonatal Diabetes Mellitus
View official trial listing →
Completed NCT NCT03061227

Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge

Not yet reported University Hospital Tuebingen 32 participants Est. completion 2020-04-30 1 site

Metabolic syndrome Other conditions: Diabetes
View official trial listing →
Completed NCT NCT03835013

Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers

Not yet reported Cambridge University Hospitals NHS Foundation Trust 26 participants Est. completion 2021-11-01 1 site

Cardiovascular disease
View official trial listing →
Active, not recruiting NCT NCT07366710

Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

Not yet reported Rigshospitalet, Denmark 36 participants Est. completion 2027-10 1 site Stand-alone

MASLD Other conditions: Glucose Metabolism
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT03061227

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.